Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5874 posts found.

Astellas plans to invest over €330m in new facility in Ireland

September 18, 2023 Manufacturing and Production Astellas Pharma, Ireland, Pharmacy, facility, manufacturing

Astellas Pharma has announced that it is preparing to submit a planning application to build a new state-of-the-art facility at …
News

Biovian announces investment in manufacturing facility in Finland

July 26, 2023 Manufacturing and Production Biovian, Pharmacy, facility, manufacturing

Biopharmaceutical based contract development and manufacturing organisation (CDMO) Biovian OY has announced an investment of over €50m to expand its …
News

Virtual Inspections: Embracing the Digital Change

July 12, 2023 Manufacturing and Production ACG, Pharmacy, digital, manufacturing, virtual inspections

Virtual inspections must become a part of companies’ repertoires if they aim to maintain quality standards in their organisations. Digital …
News
Press release

Novo Nordisk invests DKK 15.9bn to expand API production in Denmark

June 13, 2023 Manufacturing and Production APIs, Chronic Diseases, Novo Nordisk, chronic diseases

Danish healthcare company Novo Nordisk has announced that it will invest another DKK 15.9bn into expanding an existing Active Pharmaceutical …
News

Fosun Pharma and IFC partner to improve access to medicines in Africa

June 7, 2023 Manufacturing and Production Africa, Fosun Pharma, IFC, Infections and infestations, manufacturing

Shanghai Fosun Pharmaceutical Group has announced a partnership with the International Finance Corporation (IFC) with the aim of helping the …
News

Merck invests €35m in biosafety testing in Scotland

May 31, 2023 Manufacturing and Production Merck, biosafety, drug development, testing

Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland. …
News

Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London

May 24, 2023 Manufacturing and Production DNA, London, Manufacturing Facility, Touchlight, manufacturing

Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has completed the redevelopment and expansion …
News

Is the pharmaceutical sector prepared to face a titanium dioxide ban?

May 19, 2023 Manufacturing and Production ACG, EMA, EU, Titanium Dioxide

Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules In the wake of the ban on titanium dioxide (TiO2) …
News
Press release

Boehringer Ingelheim invests €350m in Europe’s largest biotech development centre

April 28, 2023 Manufacturing and Production

Boehringer Ingelheim (BI) have announced that it will invest €350m in a state-of-the-art Biologicals Development Centre (BDC) in Germany. It …
News

Trade union Unite calls for GSK staff walkouts over pay increase disputes

April 20, 2023 Manufacturing and Production

UK-based trade union Unite is pushing for staff walkouts at several GSK manufacturing sites due to disputes regarding pay increases. …
News

FDA declines Eli Lilly’s bowel disease drug over manufacturing issues

April 14, 2023 Manufacturing and Production

Pharma giant Eli Lilly’s Biologic Licence Application (BLA) for its bowel disease drug has been declined by the FDA over …
News

UK and Polish regulatory authorities approve Akari Therapeutics’ higher-yielding manufacturing process

March 30, 2023 Manufacturing and Production

Akari Therapeutics has announced that the UK’s MHRA and the Polish Office for Registration of Medicinal Products, Medical Devices and …
News

Eli Lilly invests $1bn in Limerick manufacturing facilities

March 28, 2023 Manufacturing and Production

Pharma company Eli Lilly is increasing its investment in its new manufacturing facilities in Limerick, Republic of Ireland. Today’s announcement …
News

Moderna chooses Oxfordshire for new UK facility

March 6, 2023 Manufacturing and Production

US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is …
News

REGENXBIO presents interim phase 2 data from drug developed on NAVXpress™ platform

February 13, 2023 Manufacturing and Production

REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for their drug RXG-314, which was developed by the …
News
The Gateway to Local Adoption Series

Latest content

NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases

July 30, 2026

EMA selects TrialAssure anonymisation platform for clinical trial documents

July 30, 2026

Researchers develop new antifungal compounds with improved safety profile

July 29, 2026

Lonza and Engitix partner to develop next-generation antibody-drug conjugates

July 28, 2026

Simris Group appoints Tiffany J Vora as Strategic Advisor

July 28, 2026